U.S. Regulators to Review Scientific Evidence on Testosterone Therapy for Menopausal Women

U.S. health regulators will review scientific evidence regarding testosterone use among menopausal women, examining benefits, risks, and dosages amid rising off-label usage.

Currently, no FDA-approved testosterone therapy exists for women, leading clinicians to rely on low-dose adaptations of men's products or compounded formulations.

While proponents highlight benefits for sexual desire and quality of life, specialists caution that long-term safety data remains limited and cardiovascular risks persist.